1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. COHANCE LIFESCIENCES LTD.

Cohance Lifesciences Ltd.

NSE: COHANCE | BSE: 543064

Expensive Underperformer
Download real time

1075.20 19.70 (1.87%)

79.80% Gain from 52W Low

226.4K NSE+BSE Volume

NSE 21 May, 2025 3:47 PM (IST)

Watchlist

Portfolio

Alert

Share
11S
15W
4O
1T
1,048.5

Operating Revenue TTM

Above industry Median
279.2

Net profit TTM

High in industry
26.6

Net Profit Margin TTM %

-10.2

Operating Revenue growth TTM %

Negative Operating Revenue growth TTM %
-24.7

Net Profit TTM Growth %

Negative Net Profit TTM Growth %
Board Meeting
The next board meeting for Cohance Lifesciences Ltd. is on 28 May 2025 for the purpose of Audited Results See details

Cohance Lifesciences Ltd. Credit Ratings